NasdaqCM - Nasdaq Real Time Price USD

Xylo Technologies Ltd. (XYLO)

5.20
-0.02
(-0.38%)
At close: May 9 at 4:00:00 PM EDT
5.39
+0.19
+(3.65%)
After hours: May 9 at 4:05:12 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
29,858
29,858
91,724
91,858
10,118
Cost of Revenue
23,175
23,175
79,883
77,406
5,317
Gross Profit
6,683
6,683
11,841
14,452
4,801
Operating Expense
15,177
15,177
22,656
23,033
12,997
Operating Income
-8,494
-8,494
-10,815
-8,581
-8,196
Net Non Operating Interest Income Expense
-1,051
-1,051
-1,532
-2,309
-347
Other Income Expense
-2,717
-2,717
-9,459
793
12,694
Pretax Income
-12,262
-12,262
-21,806
-10,097
4,151
Tax Provision
-257
-257
-74
111
105
Net Income Common Stockholders
-6,027
-6,027
-16,025
-9,815
6,794
Diluted NI Available to Com Stockholders
-6,027
-6,027
-16,025
-9,815
6,794
Basic EPS
-8.00
--
-25.20
-16.00
8.00
Diluted EPS
-8.00
--
-25.20
-16.00
8.00
Basic Average Shares
743.90
--
632.30
609.63
575.90
Diluted Average Shares
743.90
--
632.30
609.63
575.90
Total Operating Income as Reported
-8,017
-8,017
-23,321
-13,784
-9,895
Total Expenses
38,352
38,352
102,539
100,439
18,314
Net Income from Continuing & Discontinued Operation
-6,027
-6,027
-16,025
-9,815
6,794
Normalized Income
-3,589.19
-3,589.19
-12,582.72
-13,053
-7,192.04
Interest Expense
1,051
1,051
1,532
2,309
347
Net Interest Income
-1,051
-1,051
-1,532
-2,309
-347
EBIT
-11,211
-11,211
-20,274
-7,788
4,498
EBITDA
-7,506
-7,506
-16,295
-4,551
4,818
Reconciled Cost of Revenue
23,175
23,175
79,883
77,406
5,317
Reconciled Depreciation
3,705
3,705
3,979
3,237
320
Net Income from Continuing Operation Net Minority Interest
-6,027
-6,027
-16,025
-9,815
6,794
Total Unusual Items Excluding Goodwill
-2,490
-2,490
-3,454
3,238
14,349
Total Unusual Items
-2,490
-2,490
-3,454
3,238
14,349
Normalized EBITDA
-5,016
-5,016
-12,841
-7,789
-9,531
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-52.19
-52.19
-11.72
0
362.96
12/31/2021 - 8/5/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MODD Modular Medical, Inc.
1.0000
-1.96%
 
HSCS HeartSciences Inc.
3.4286
-1.76%
 
LFWD Lifeward Ltd.
1.3700
0.00%
 
BBLG Bone Biologics Corporation
0.7497
+8.65%
 
SERA Sera Prognostics, Inc.
2.2200
+4.72%
 
AMIX Autonomix Medical, Inc.
1.7800
+4.71%
 
ADGM Adagio Medical Holdings, Inc.
1.4600
+5.04%
 
NMTC NeuroOne Medical Technologies Corporation
0.6152
-1.57%
 
ZIMV ZimVie Inc.
8.76
-4.68%
 
ICCM IceCure Medical Ltd
1.0300
0.00%